Microheterogeneity, standardization and characterization in glycoprotein drugs

Robert P. Bondaryk*, Nicolle H. Packer

*Corresponding author for this work

Research output: Contribution to journalComment/opinion

Abstract

Problems with chemical characterization of glycobiopharmaceuticals exemplify well the difficulties that have beset developers of recombinant protein drugs. Could new analytical techniques see such products take their place alongside small molecules in the regulatory rulebook?

Original languageEnglish
Pages (from-to)31-32
Number of pages2
JournalCurrent Drug Discovery
Issue numberJUNE
Publication statusPublished - Jun 2004
Externally publishedYes

Fingerprint Dive into the research topics of 'Microheterogeneity, standardization and characterization in glycoprotein drugs'. Together they form a unique fingerprint.

Cite this